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Thermoascus aurantiacus†
Raushan K. Singh, a Benedikt M. Blossom, b D. A. Russo, ‡c B. van Oort, d
R. Croce, d P. E. Jensen, c C. Felbyb and M. J. Bjerrum *a
Lytic polysaccharide monooxygenases (LPMOs) are copper-containing enzymes which promote the
degradation of recalcitrant polysaccharides like cellulose or chitin. Here, we have investigated the
thermostability of an LPMO from Thermoascus aurantiacus (TaLPMO9A). TaLPMO9A was found to retain
most of its initial activity after incubating at 100 C while its apparent melting temperature (Tm) is 69 C
at neutral pH. Interestingly, our studies show that holoTaLPMO9A, apoTaLPMO9A and deglycosylated
TaLPMO9A can fold back to their original conformation upon lowering the temperature. In the presence
of b-mercaptoethanol the protein does not refold. Activity of TaLPMO9A and refolded TaLPMO9A was
studied by an Amplex® Red assay as well as by TaLPMO9A catalysed oxidation of phosphoric acid
swollen cellulose (PASC). These studies conﬁrm the functional regain of TaLPMO9A activity upon going
through one cycle of unfolding and refolding. The thermal unfolding and refolding of TaLPMO9A was
measured spectroscopically. Utilizing the two-state model, detailed thermodynamic parameters were
obtained for holoTaLPMO. Furthermore, we have investigated the kinetics of TaLPMO9A unfolding and
refolding. Our results have implications in understanding LPMO stability, which is crucial for the eﬃcient
application of LPMOs as biocatalysts during biomass degradation.Introduction
Lignocellulosic biomass, predominantly consisting of recalci-
trant plant cell wall polymers, constitutes the largest source of
biomass of the biosphere.1,2 Therefore, the development of
strategies to harness lignocellulosic biomass may hold the key
to the production of green renewable energy and its bioproducts
and has huge potential to reduce the environmental pollution
caused by petroleum-based energy sources.3,4 One potential
exploitation route is enzymatic degradation, by utilizing
a variety of hydrolytic enzymes. One notable development of
this eld was the discovery of a group of copper-dependent
enzymes called lytic polysaccharide monooxygenases
(LPMOs).5,6 LPMOs cleave b-(1/4) glycosidic bonds by oxidis-
ing the C1 and/or C4 carbon in polysaccharides.6–10 LPMOs haveenhagen, Copenhagen, Denmark. E-mail:
l Resource Management, University of
l Sciences, University of Copenhagen,
teit Amsterdam, Amsterdam, Netherlands
tion (ESI) available. See DOI:
and Analytical Chemistry, Bioorganic
a, Jena, Germany.
2been identied in fungi, bacteria, viruses, invertebrates, and
algae.11–13 They are currently classied into seven auxiliary
activities families (AA9, AA10, AA11, AA13, AA14, AA15 and
AA16) following the carbohydrate-active enzymes (CAZy) data-
base.14–16 All LPMOs have a characteristic at, solvent exposed
binding surface and an essential, highly conserved, mono-
nuclear active site type-2 copper coordinating, t-shaped histi-
dine-brace.5,10,17 The crystal structure and EPR spectra of an
LPMO from Thermoascus aurantiacus (TaLPMO9A) provided
valuable structural insights into the LPMO active-site and
histidine brace coordination sphere of the copper ion.5 In
presence of a soluble redox active agent such as ascorbic acid,
TaLPMO9A has been reported to oxidize substrate at both C1
and C4 carbons. However, TaLPMO9A predominantly releases
C4-oxidized oligosaccharides.18 Addition of TaLPMO9A to the
cocktail of cellulose-degrading enzymes had a boosting eﬀect
on cellulose saccharication. Here, the operational stability of
LPMOs is crucial due to the long incubation period of cellulose
saccharication.18
Although LPMOs have been studied intensively in recent
years, the focus of the work has been predominantly on eluci-
dating the reaction mechanism, substrate specicity and char-
acterization of new family members.5,19–28 To date, there are very
few studies dealing with LPMO stability, a crucial aspect for
commercial success as a biocatalyst. In particular, thermal
stability is of great interest due to the fact that catalytic enzymesThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinestart to unfold and get inactivated with increasing tempera-
ture.29 Unfolding and thermal stability in LPMOs has been
explored in a recent study showing that MtLPMO9B from
Myceliophthora thermophila C1 show irreversible unfolding at
temperature higher than 70 C.30 In another study, site-directed
mutagenesis was applied to improve the Tm of the Streptomyces
coelicolor LPMO10C (ScLPMO10C) up to 12 C by introducing
two additional disulphide bridges.31 The apparent melting
temperatures for TaLPMO9A (with and without the methylated
N-terminal His1 residue) was found to be 77 C using diﬀer-
ential scanning calorimetry.18 However, the potential revers-
ibility of thermal unfolding in LPMOs and the thermodynamics
of unfolding and refolding have not been studied till now.
Thermodynamic studies of LPMOs can provide valuable
insights into the structural changes they undergo at higher
temperature. Additionally, information on the reversibility of
thermal unfolding in LPMOs can contribute to the application
of LPMOs as biocatalysts for thermal sterilization and on–oﬀ
control in bioreactors.32
In the present work, we show that TaLPMO9A is highly
thermostable with a characteristic transition midpoint (Tm) for
the unfolding of the backbone of 69 C at neutral pH.
Furthermore, it is demonstrated that thermal unfolding of
TaLPMO9A is reversible. We performed a spectroscopic study of
the thermal unfolding/refolding of TaLPMO9A, utilizing
a simple two-state model, thus allowing the calculation of
thermodynamic parameters of unfolding/refolding. The results
of this study provide insight into the thermal unfolding mech-
anism and stability at higher temperature.Materials and methods
Materials
All chemicals were of the highest purity grade available and
were purchased from Sigma-Aldrich unless stated otherwise.
Ampliu™ Red (10-acetyl-3,7-dihydroxyphenoxazine) was
purchased from Cayman chemical company. TaLPMO9A
(Thermoascus aurantiacus) expressed in Aspergillus oryzae was
donated by Novozymes A/S (Bagsværd, Denmark). PNGase F
(peptide-N-glycosidase F) from Elizabethkingia miricola and
horseradish peroxidase (HRP) were purchased from Sigma-
Aldrich (St. Louis, USA).Purication of TaLPMO9A
Copper(I) chloride was used to saturate TaLPMO9A (Thermoas-
cus aurantiacus) under anaerobic environment on ice for 2 h.
The TaLPMO9A preparation was then ltered and injected into
an A¨KTA chromatography system (Amersham Pharmacia
Biotech, Sweden) equipped with a Hiload 26/60 Superdex 75
prep grade column (Pharmacia Biotech) equilibrated with
20 mM MOPS buﬀer (pH 7.0). HoloTaLPMO9A (i.e. copper
loaded TaLPMO9A, hereaer TaLPMO9A) was eluted in a single
peak using 20 mM MOPS buﬀer (pH 7.0) with a ow rate of 1
mL min1. The fractions corresponding to the single peak were
pooled, concentrated using an Amicon Ultra-15 centrifugal lter
(3 kDa, Merck Millipore Ltd. Ireland) and stored at 4 C forThis journal is © The Royal Society of Chemistry 2019further use. The puried TaLPMO9A was analysed for purity by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) using a Mini-PROTEAN TGX precast gel from Bio-
Rad Laboratories with a gradient of 4–15% polyacrylamide.
Protein bands were visualized by staining with Coomassie blue.
Precision Plus Protein Standard was used for apparent mass
determination.
To obtain apoTaLPMO9A (i.e. copper free TaLPMO9A),
puried holoTaLPMO9A was dialyzed using a D-tube Dialyzer
Maxi (6–8 kDa) from Millipore (Billerica, MA, USA). A D-tube
loaded with puried holoTaLPMO9A was suspended in
a beaker containing 20 mM phosphate buﬀer (pH 7.0) supple-
mented with 10 mM EDTA. The dialysis was performed at 4 C
for 12 h. During the course of dialysis, the buﬀer was continu-
ously stirred using a magnetic stirrer and was replaced twice.
Aer 12 h of dialysis, the apoTaLPMO9A was buﬀer exchanged
and concentrated using Amicon Ultra-15 centrifugal lter (3
kDa, Merck Millipore Ltd. Ireland).Copper and protein estimation
The copper content of the TaLPMO9A was analysed using high
resolution inductively coupled plasma-MS (ICP-MS) using an
Aurora M90 ICP-MS system (Bruker, Germany). Data were
collected using Bruker Quantum soware. Optimization
parameters for plasma ow, auxiliary ow, sheath gas nebulizer
ow were 16.5, 2.0, 0.2, and 1.0 L min1, respectively. The metal
content was determined by comparison with standard curve
generated from known concentrations of internal standard
solution. Standard curve was plotted from 0 to 50 ppb using IV-
ICPMS-71A solution (Inorganic ventures, Christiansburg, VA,
USA). Instrument was calibrated and 2% nitric acid was run as
control before samples. TaLPMO9A (1–2 mg mL1) was appro-
priately diluted in 2% nitric acid. An average of three analyses of
each sample was taken.
Protein concentrations of puried TaLPMO9A were esti-
mated based on its absorbance at 280 nm using a NanoDrop
spectrophotometer (Fisher Scientic, USA). The TaLPMO9A
sequence was used to calculate the extinction coeﬃcient of the
TaLPMO9A (3280 ¼ 45 630 M1 cm1) with an online tool
available at https://web.expasy.org/protparam/.Deglycosylation and mass spectroscopy (MS)
For deglycosylation, TaLPMO9A (1 mg mL1, 50 mL) was treated
with PNGase F (500 units mL1, 2 mL) in 20 mM ammonium
bicarbonate (pH 8.0). The reaction mixture was incubated at
37 C for 12 h and then heated to 100 C for 5 minutes to stop
the reaction. The reaction mixture containing deglycosylated
TaLPMO9A was frozen for subsequent MS analysis.33
The intact molecular weight analyses were performed using
a Bruker microTOF focus electrospray mass spectrometer
(Bruker Daltonik GmbH, Germany). Samples were washed on
a MassPREP On-Line Desalting column (2.1  10 mm; Waters,
USA) and introduced to the electrospray source with a ow rate
of 200 mL h1 using an Agilent LC system. Data analysis was
performed with DataAnalysis version 3.3 (Bruker DaltonikRSC Adv., 2019, 9, 29734–29742 | 29735
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View Article OnlineGmbH, Germany). The molecular weight of the samples was
calculated by maximum entropy deconvolution.
Circular dichroism (CD)
CD spectra were recorded on a Jasco J-815 circular dichroism
spectrometer equipped with a temperature-controlled cell
holder. The instrument was ushed with nitrogen, with a ow
rate of 10 L min1 throughout the experiment. The transition
from the folded state to the unfolded state of the TaLPMO9A
(0.66 mg mL1) was recorded at 222 nm using a 1 mm cuvette.
Temperature ranged from 30 to 90 C (unfolding) and 90 to
30 C (refolding) with four diﬀerent heating and cooling rates,
1.0 C, 0.5 C, 0.2 C and 0.1 Cmin1. The fraction of the folded
protein (fN) at each temperature is calculated using the
expression fN ¼ (QU  QT)/(QU  QN), where QN and QU are the
measured ellipticity of the folded and the unfolded protein
respectively.34 QT is the ellipticity at each temperature. For the
“far-UV” spectral region (260–180 nm) CD spectra was recorded
at a bandwidth of 2 nm using 0.1 mm round cuvette at 25 C. All
measurements were performed in 20 mMMOPS buﬀer (pH 7.0).
Data were analysed with SpectraManager 2 (Jasco, Germany). To
calculate the content of secondary structural elements of
unfolded and refolded TaLPMO9A online tool available at
http://bestsel.elte.hu/index.php was used.35 CD spectra was
used from 190 to 250 nm. For the thermodynamic functions of
the TaLPMO9A unfolding/refolding we used the transition
curve, van't Hoﬀ's plot and van't Hoﬀ's equation. DH and DS
were derived from the slope and intercept of van't Hoﬀ's plot,
respectively.
Thermal unfolding based on intrinsic tryptophan uorescence
For each condition, 10 mL of sample per capillary were prepared.
The protein samples were loaded into UV capillaries (Nano-
Temper Technologies, Germany) and experiments were carried
out using the NanoTemper Tycho NT.6 (NanoTemper Tech-
nologies, Germany). The temperature gradient was set to an
increase of 20 C min1 in a range from 35 C to 95 C. Protein
unfolding was measured by detecting the temperature-
dependent change in tryptophan uorescence at emission
wavelengths of 330 and 350 nm. Inection temperatures (Ti)
were determined by detecting the maximum of the rst deriv-
ative of the uorescence ratios (F350/F330). For this, an 8th order
polynomial t was calculated for the transition region. Next, the
rst derivative of the t was formed and the peak position (at Ti)
was determined.
Unfolding and refolding kinetics
The kinetics of thermal unfolding was monitored using time
course measurement on a circular dichroism spectrometer. The
transition from the folded state to the unfolded state of TaLP-
MO9A (0.5 mg mL1) was recorded by following change in
ellipticity (222 nm) upon heating the protein at 72, 74, 76, 78,
and 80 C for 1 hour. Spectra were recorded in pre-equilibrated
buﬀer at each temperature. Single exponential decay equation,
fN ¼ yf + aekut was applied to t the folded protein fraction (fN),
where ku and t are the rate of unfolding and time, respectively.3429736 | RSC Adv., 2019, 9, 29734–29742The activation energy (Eua) of unfolding was determined from
the slope of an Arrhenius plot.
The refolding kinetics of TaLPMO9A were performed by
monitoring the change in ellipticity (222 nm) of the unfolded
TaLPMO9A. TaLPMO9A was unfolded by heating at 80 C for
10 min immediately before the refolding kinetic experiment.
The refolding kinetics study was carried out by allowing the
unfolded TaLPMO9A to refold at 60, 62, 64, 66, and 68 C for 3
hours. As described above, the rate of refolding (kf) and the
activation energy of refolding (Efa) were estimated by tting the
fN using single an exponential decay equation and from the
slope of an Arrhenius plot, respectively.
Amplex® Red assay
In the absence of substrate, LPMOs undergo a futile side reac-
tion thereby producing H2O2. The produced H2O2 is directly
proportional to the amount of LPMO added to the assay
mixture. H2O2 produced as the result of side reaction is then
determined by HRP coupled conversion of Amplex® Red to
resuron.36 Horseradish peroxidase (HRP)-coupled Amplex®
Red (10-acetyl-3,7-dihydroxyphenoxazine) assay was performed
on SpectraMax M2 multi-detection microplate reader (Molec-
ular Devices, USA) using a black 96-well plate with clear bottom
from Nunc (Thermo Fisher, USA).36 All the reactions were per-
formed in 20 mM sodium phosphate buﬀer (pH 6.0) at 37 C.
200 mL of reaction mixture contained 100 mM EDTA, 80 mM
ascorbate, 50 mM Ampliu™ Red, 20 U mL1 HRP and 2.0 mg
mL1 TaLPMO9A. Resorun uorescence was recorded with an
excitation and emission wavelength of 557 nm and 583 nm,
respectively. Fluorescence was measured from the bottom for
10 min with 5 s shaking before measurements began.
Enzymatic oxidation of phosphoric acid swollen cellulose
(PASC)
PASC was prepared by treating microcrystalline cellulose (avi-
cel) with phosphoric acid as described by Wood et al. (1988).37
Avicel (4 g) was suspended into phosphoric acid, 100 mL (86%
w/v) at 60 C and stirred for an hour. Mili-Q water (1900 mL) was
slowly dripped into the solution. The prepared suspension was
then moved to 4 C for sedimentation. The supernatant was
then discarded and the remaining suspension was washed with
Mili-Q water at least four times. The pH of the suspension was
neutralized by Na2CO3 and stored at 4 C in the dark until
further use.
PASC oxidation was performed using both the puried
TaLPMO9A and the refolded TaLPMO9A in the presence of
ascorbate (2 mM) in 100 mM citrate buﬀer (pH 6.2) at 50 C for
19 h. Reaction was terminated by the addition of 0.1 M NaOH
and samples were centrifuged immediately. The separated
supernatant was then ltered (0.22 mM) and analysed for the
presence of oligosaccharides using High-Performance Anion
Exchange Chromatography (HPAEC).
High-performance anion exchange chromatography
Oligosaccharides released from TaLPMO9A catalysed oxidation
of PASC were detected using an ICS-5000+ system withThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinea CarboPac PA1 column (two 2  50 mm guard columns fol-
lowed by a 2  250 mm analytical column) and a PAD detector
(Thermo Scientic, USA) as described by Mo¨llers et al. (2017).38
The following gradients were used for the elution (eluent A,
0.1 M NaOH; eluent B, 1 M NaOAc in 0.1 M NaOH): 100% A : 0%
B to 90% A : 10% B (10 min), then to 70% A : 30% B (25 min)
and lastly 0% A : 100% B (30 min). 100% A : 0% B was used for
the column reconditioning. The peaks for cello-
oligosaccharides were interpreted following the elution
proles of commercially available non-oxidized oligosaccha-
rides (DP2–DP6). Based on previous publications the peaks
appearing aer 25 min correspond to the C4-oxidized
products.21,38Results and discussion
The TaLPMO9A is a widely studied LPMO from Thermoascus
aurantiacus due to its industrial relevance in decomposing
lignocellulosic biomass.5,39 However, very little is known
regarding the thermal stability and structural properties at
elevated temperatures of this enzyme. Therefore, TaLPMO9A
was copper loaded and puried until it was free from any visible
impurities (Fig. S1†). We then proceeded to undertake
a detailed study of the thermal stability and thermodynamics of
folding/unfolding of the TaLPMO9A.Thermal stability of TaLPMO9A
Initially, the thermal stability of the TaLPMO9A was investi-
gated by measuring the activity of the enzyme aer incubation
at elevated temperature. Surprisingly, only a gradual decrease in
activity was observed with increasing incubation time at 100 C
(Fig. 1A). The TaLPMO9A showed only 19% decrease in activity
aer 30 min of incubation at 100 C. The activity was reduced to
72% aer 45 min of incubation at 100 C. In order to analyse
changes in the secondary structure of the protein, we proceeded
with a CD spectroscopy based analysis. The far-UV spectralFig. 1 Thermal stability of TaLPMO9A. (A) TaLPMO9A activity
measured by the Amplex® Red assay at 37 C after exposure to 100 C
for diﬀerent time intervals. TaLPMO9A was kept on ice for 10 min
before performing the Amplex® Red assay. Amplex® Red assay
mixture contained 100 mM EDTA, 80 mM ascorbate, 50 mM Ampliﬂu™
Red, 20 U mL1 HRP and 2.0 mg mL1 TaLPMO9A. (B) CD spectra of
TaLPMO9A (1 mg mL1, in 20 mM MOPS buﬀer, pH 7.0) at 25 C after
exposure to 100 C for diﬀerent time intervals. An average buﬀer
baseline spectrumwas subtracted from average of three scans at each
condition.
This journal is © The Royal Society of Chemistry 2019region showed two peaks corresponding to 222 nm and 195 nm
(Fig. 1B). It is clear that the secondary structure changes grad-
ually with an increase of incubation time at 100 C. The 222 nm
minima start to shi to 200 nm and, simultaneously, the
195 nm peak gradually disappeared with increasing incubation
time. Aer 120 min, the 222 nm minima disappeared and
distinctly appeared at 200 nm. This shi towards shorter
wavelength clearly indicates that the TaLPMO9A is unfolding
but not into a fully random structure, as described before for
LPMOs 9B and 9D from Myceliophthora thermophila C1.30
Furthermore, CD spectra in far-UV spectral region for TaLP-
MO9A passed through an isosbestic point at 215 nm at all
temperatures from 40 to 90 C (Fig. S2†). This suggests that in
the temperature range of 40 to 90 C, unfolding of TaLPMO9A is
a two-state process without formation of signicant amounts of
an intermediate.
Next we monitored the stability of TaLPMO9A by intrinsic
protein uorescence. TaLPMO9A contains ten tryptophan
residues, therefore, changes in the tryptophan uorescence
intensity upon protein unfolding allow for the determination
of a dened transition point (Fig. 2). From these experiments,
apparent midpoint transition temperatures, in the following
referred to as Ti were determined from the rst derivative of
the uorescence traces (Fig. S3A†). The eﬀect of TaLPMO9A
concentration on thermal stability was monitored for
concentrations ranging from 0.1 mg mL1 to 5 mg mL1. Ti
decreased with increased TaLPMO9A concentration
(Fig. S3A†). The decrease in Ti at high TaLPMO9A concentra-
tions may be attributed to a reversible co-operative interaction
of denatured monomeric protein during the unfolding.40
Additionally, Ti determined in diﬀerent buﬀer systems and pH
environments (pH 4.0 to pH 9.0) revealed pronounced eﬀects
of both (Fig. 2B and S3B†). The Ti value of TaLPMO9A
decreased from acidic pH to alkaline condition. The highest Ti
(89.5 C) was found to be at pH 5.0 in citrate buﬀer (20 mM).
The decrease in Ti at pH values lower than 5.0, suggests that
the protonation has destabilising eﬀect on TaLPMO9A.41 On
the other hand, if we compare the eﬀect of diﬀerent buﬀer
systems (citrate, phosphate and trizma), TaLPMO9A seems to
be more stable in Trizma buﬀer.Fig. 2 Thermostability at various conditions. Stability of TaLPMO9A at
diﬀerent protein concentrations (20 mM MOPS buﬀer, pH 7.0) (A) and
at various pH (1 mg mL1 of TaLPMO9A) (B) determined by tempera-
ture-dependent change in tryptophan ﬂuorescence at emission
wavelengths of 330 and 350 nm using the NanoTemper Tycho NT.6.
RSC Adv., 2019, 9, 29734–29742 | 29737
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View Article OnlineUnfolding and refolding
Following the observation that the TaLPMO9A was still active
aer incubation at 100 C we proceeded to probe the unfolding
reversibility of TaLPMO9A by following the CD signal at 222 nm
during gradual heating to 90 C followed by cooling down to
30 C. TaLPMO9A was subjected to unfolding by increasing the
temperature from 30 C to 90 C with 1 C min1 temperature
ramp in 20 mMMOPS buﬀer (pH 7.0) (Fig. 3A). The TaLPMO9A
showed almost no change in ellipticity with the increase in
temperature up to 50 C. A steep decrease in ellipticity was
observed aer 70 C indicating the onset of unfolding. The
apparent Tm was observed to be 74.3 C for the TaLPMO9A.
Following similar experimental conditions, the Tm for apo-
TaLPMO9A and deglycosylated TaLPMO9A were determined to
be 65.2 and 67.9 C, respectively (Fig. 3B and C). The lower Tm
for the apoTaLPMO9A is due to the absence of copper from the
active site leading to a less stable structure. This has also been
reported for LPMOs from Neurospora crassa and Bacillus amy-
loliquefaciens.42 Additionally, in regards to the deglycosylated
TaLPMO9A, the decreased Tm value conrms that the sugar
groups linked to the surface of the TaLPMO9A may be acting as
a protectant against harsh physical conditions, including high
temperature. To investigate the refolding of thermally unfoldedFig. 3 Thermal unfolding of TaLPMO9A. The molar ellipticity measured
30 to 90 C for TaLPMO9A (A), apoTaLPMO9A (B) and deglycosylated
TaLPMO9A was recorded using 1 mm cuvette, temperature ranging from
for unfolding. Similarly, 1.0 C min1 cooling rates was used for refolding
refolding, respectively. (D) shows the far-UV CD spectra measured at t
TaLPMO9A and refolded TaLPMO9A. Far-UV spectral region (260–190
residue ellipticity is calculated on the basis of mean residue weight (M
Amplex® Red assay. TaLPMO9A was subjected to unfolding and refolding
the rate of 1.0 C min1. Amplex® Red assay was performed in 20 mM s
TaLPMO9A catalysed oxidation of cellulose analysed by HPAEC. Refolded
then cooling it from 90 to 30 C at the rate of 1.0 C min1. PASC oxidati
and in citrate buﬀer (pH 6.2, 100 mM). The peaks were assigned accordi
oligosaccharides. DP2, cellobiose; DP3, cellotriose; DP4, cellotetraose;
keto aldose) peaks appear after a retention time of 30 min.
29738 | RSC Adv., 2019, 9, 29734–29742TaLPMO9A, the protein was cooled down from 90 to 30 C by
gradually decreasing the temperature at 1 C min1. During the
refolding cycle, the TaLPMO9A was found to be in an unfolded
state down to 60 C upon which it started to refold, and it
regained the initial minimal ellipticity at 222 nm of the
completely folded state at 50 C. It is interesting to note that
TaLPMO9A thermal unfolding is reversible in all three forms i.e.
holoTaLPMO9A, apoTaLPMO9A and deglycosylated TaLPMO9A.
This indicates strongly that neither the coordinated copper-ion
at the active site nor the glycosylation have an impact on the
reversibility of LPMO refolding.
The CD spectra in the far-UV spectral region (190–260 nm) of
the native TaLPMO9A were found to be nearly identical before
unfolding (at 25 C) and aer going through the unfolding and
refolding cycle (25 C) (Fig. 3D). The calculated secondary struc-
tures derived from the far-UV CD spectrum for TaLPMO9A before
unfolding (at 25 C) and aer going through the unfolding/
refolding cycle (25 C) suggests a regaining of the secondary
structure (Fig. 3D). The puried TaLPMO9A before unfolding
contains 12.4% a helices, 31.5% b sheets, 13.5% turn and 42.6%
others. Upon going through unfolding/refolding cycle the
secondary structure components for TaLPMO9A were calculated
to be 11.7% a helices, 36.0% b sheets, 11.8% turns and 40.5%at 222 nm was monitored continuously in the temperature range from
TaLPMO9A (C). The transition from folded state to unfolded state of
30 to 90 C and 90 to 30 C with a constant increment of 1.0 Cmin1
of TaLPMO9A. Solid and hollow squares represent the unfolding and
he beginning of unfolding experiment and after the refolding step of
nm) was recorded using 0.1 mm round cuvette at 25 C. The mean
RW). (E) Activity of TaLPMO9A and refolded TaLPMO9A measured by
by heating it from 30 to 90 C and then cooling it from 90 to 30 C at
odium phosphate buﬀer (pH 6.0) at 37 C. (F) TaLPMO9A and refolded
TaLPMO9A was prepared by heating TaLPMO9A from 30 to 90 C and
on was performed for 19 hours with 2 mM ascorbate as electron donor
ng to the elution proﬁle of commercially available non-oxidized cello-
DP5, cellopentaose; DP6, cellohexaose. The C4-oxidized glucose (4-
This journal is © The Royal Society of Chemistry 2019
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View Article Onlineothers. The crystal structure of TaLPMO9A (PDB: 2YET) shows
11.6%, 30.7% and 57.7% of a helices, b sheets, and others,
respectively. The increase in b sheet might be an actual eﬀect but
could be due to experimental variation. Nonetheless, the refolded
TaLPMO9A almost entirely regains its native helical content.
To compare the catalytic activity of TaLPMO9A and refolded
TaLPMO9A (aer unfolding/refolding cycle), Amplex® Red and
PASC oxidation assays were performed under standard experi-
mental conditions. As shown in Fig. 3E, the Amplex® Red assay
indicated no signicant diﬀerence in the activities for TaLPMO9A
and refolded TaLPMO9A. Similarly, no measureable diﬀerences
were seen in the oxidized products for TaLPMO9A and refolded
TaLPMO9A catalysed oxidation of PASC (Fig. 3F). Thus, it is evident
from the results that the refolded TaLPMO9A regained its oxidative
activity aer going through an unfolding/refolding cycle.
To further investigate the reversibility of thermal unfolding,
the TaLPMO9A unfolding and refolding was also performed in
the presence of the cysteine disulphide bond reducing reagent
b-mercaptoethanol (b-ME, added before heating). The data
shown in Fig. 4 clearly indicates that, with increasing temper-
atures from 30 to 90 C the TaLPMO9A unfolds. However, when
the unfolded TaLPMO9A is cooled down from 90 to 30 C in the
presence of b-ME the refolding process is not observed. The lack
of reversibility in the unfolded TaLPMO9A is ascribed to the
prevention of reformation of the disulphide bonds. The TaLP-
MO9A crystal structure (2YET) contains two disulde bonds in
each subunit (Cys97–Cys101 and Cys56–Cys178) (Fig. S4†).5
When the TaLPMO9A unfolds, the disulphide bonds are
reduced by b-ME. From the above results it can be concluded
that during the unfolding of TaLPMO9A, in absence of b-ME,
the protein retains its native disulphide bonds intact.43 The two
disulphide bonds are thus critical for the structural stability of
the TaLPMO9A at high temperatures.31Fig. 4 Thermal unfolding of TaLPMO9A in presence of b-ME. (A) The
molar ellipticity measured at 222 nm was monitored continuously in
the temperature range from 30 to 90 C for the TaLPMO9A (0.66 mg
mL1) in the presence of b-ME (10 mM). The transition from folded
state to unfolded state of TaLPMO9A was recorded using a 1 mm
cuvette, with temperatures ranging from 30 to 90 C and 90 to 30 C
with an increment of 1.0 C min1 for unfolding and a 1.0 C min1
cooling rate for refolding. Solid and hollow squares represent the
unfolding and refolding, respectively. (B) The far-UV CD spectra
measured for TaLPMO9A and b-ME (10 mM) treated TaLPMO9A. b-ME
(10 mM) was mixed with TaLPMO9A (1 mg mL1) and incubated at
100 C for 10 minutes. The far-UV spectral region (260–190 nm) was
recorded using a 0.1 mm round cuvette at 25 C. The mean residue
ellipticity is calculated on the basis of mean residue weight (MRW).
This journal is © The Royal Society of Chemistry 2019Thermodynamic parameters
To study the thermodynamic parameters of unfolding and
refolding of TaLPMO9A with intact disulphide bonds, we recor-
ded the ellipticity at 222 nm with diﬀerent temperature ramps
(1.0, 0.5, 0.2 and 0.1 C min1). The ellipticity (222 nm) was
measured from 25 C to 90 C and from 90 C to 25 C for
TaLPMO9A unfolding and refolding, respectively (Fig. 5).
Unfolding of TaLPMO9A started at 68, 66, 64 and 62 C for a 1.0,
0.5, 0.2, and 0.1 C min1 temperature ramp, respectively
(Fig. 5A). Accordingly, a decrease in melting temperature (Tm)
with slower heating rates was also observed (Fig. 5A and Table
S1†). This indicates that the unfolding is a process that, at high
heating rates is limited by the heating rate. Aer achieving the
unfolding at 90 C, where ellipticity (222 nm) became constant,
we also monitored the refolding of TaLPMO9A by decreasing the
temperature from 90 C to 25 C applying various cooling rates
(1.0, 0.5, 0.2 and 0.1 C min1) (Fig. 5B). The transition curve for
refolding at various cooling rates (Fig. S5B†) showed diﬀerences
in the onset of refolding (see Methods section for the calculation
of the folded fraction). Consequently, a lower half refolding
temperature ðT 0mÞ was observed with faster cooling rate (Fig. 5B
and Table S1†).
For a specic heating and cooling rate, such as 1 C min1,
the melting temperature (Tm) is much higher than the half
refolding temperature ðT 0mÞ which indicates hysteresis in the
unfolding and refolding process of TaLPMO9A.44 From this
diﬀerence in Tm and T 0m it can be inferred that during a fast
temperature ramp, there is not suﬃcient time for TaLPMO9A to
reach an equilibrium at a specic temperature, thereby, causing
hysteresis. However, this hysteresis decreases with a decreasing
temperature ramp for the unfolding and refolding cycle. Table
S1† shows that the diﬀerence between Tm and T 0m decreased
with a decrease in temperature ramp (from 1.0 C min1 to
0.1 C min1). Also, the decrease in T 0m is more prominent than
that of Tm. This implies that TaLPMO9A refolding process is
much slower than that of unfolding. The unfolding and
refolding process was analyzed by applying the simplest model
(N4U). Here, the TaLPMO9A is assumed to exist in the native
(N) or in the unfolded (U) state. Fig. 6 and S5† show a plot of theFig. 5 Unfolding and refolding of TaLPMO9A. Reversible thermal
unfolding of TaLPMO9A. The ellipticity at 222 nm was monitored
continuously in the temperature range from (A) 40 to 80 C and (B) 80
to 40 C at diﬀerent temperature ramps. Thermal unfolding and
refolding were performed at 0.1, 0.2, 0.5, and 1.0 C min1 tempera-
ture ramps. The scans at each condition were smoothed using
Savitzky–Golay ﬁlter with a 5 point and polynomial order 2.
RSC Adv., 2019, 9, 29734–29742 | 29739
Fig. 7 Unfolding and refolding kinetics. (A) Variation in folded fraction
during TaLPMO9A (0.5 mg mL1, in 20 mM MOPS buﬀer, pH 7.0)
unfolding as a function of time at diﬀerent temperatures. The transition
from the folded state to the unfolded state was recorded by following
change in ellipticity (222 nm) using a 1 mm cuvette. (B) Variation in
folded fraction during TaLPMO9A (0.5 mg mL1, in 20 mM MOPS
buﬀer, pH 7.0) refolding as a function of time by cooling it down at
diﬀerent temperatures. The transition from the unfolded state to the
folded state was recorded by following change in ellipticity (222 nm)
using a 1 mm cuvette. The folded protein fraction is presented as fN.
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View Article Onlineapparent transition temperature and the apparent van't Hoﬀ
enthalpy change (DH). Both the apparent Tm and the apparent
DH were found to be dependent on the scanning rate. DH of
TaLPMO9A unfolding (0.1 C min1 heating rate) and refolding
(0.1 C min1 cooling rate) was observed to be 245 and
247 kJ mol1, respectively (Fig. 6 and Table S2†). We have
extrapolated the unfolding and refolding data from Fig. 6A by
considering the average of unfolding/refolding to obtain values
that should correspond to values close to the equilibrium. At
equilibrium, the CD spectra were very similar before and aer
a heating cycle and unfolding and refolding transitions were
super-imposable. The reversibility and equilibrium condition
found in the temperature-induced unfolding of TaLPMO9A
allowed the estimation of DH, DS, and Tm. DH and DS values for
TaLPMO9A unfolding/refolding were found to be 246 kJ mol1
and 0.72 kJ mol1, respectively (Fig. S6 and Table S2†). The
native state of TaLPMO9A is stabilized at 25 C and 37 C by
a free energy change (DG) of 13 and 4 kJ mol1, respectively. The
apparent Tm of TaLPMO9A was estimated to be 69.3 C under
conditions close to the equilibrium. DH for glutamate dehy-
drogenase, a hyperthermostable enzyme from Thermotoga
maritima is reported to be 218 kJ mol1 (at pH 7.15).45Unfolding and refolding kinetics
To investigate the kinetics of TaLPMO9A unfolding, we recor-
ded the ellipticity at 222 nm at diﬀerent temperatures (from 72
to 80 C) for 1 h using a CD spectrophotometer (Fig. 7). The
protein was unable to unfold, or the unfolding was very slow, at
temperatures below 72 C. At higher temperatures (80, 78 and
76 C) TaLPMO9A starts to unfold rapidly and unfolded
completely within 15 min at 80 and 78 C. Unfolding at 72 and
74 C was comparably slower than the unfolding at 76, 78 and
80 C. The folded protein fraction (fN) was reduced to less than
0.3 within 30 min at all tested temperatures from 72 to 80 C
(Fig. 7A). The rate of unfolding (ku) was derived from the
exponential t of fN overtime (Fig. S7A†). The activation energy
of unfolding (Eua), derived from the slope of ku in the Arrhenius
plot (Fig. S7B†), was calculated to be 171 kJ mol1.Fig. 6 Thermodynamic calculation using van't Hoﬀ plot. Reversible
thermal unfolding of TaLPMO9A. (A) Transition curve for the ellipticity
measured at 222 nm in the temperature range from 25 to 80 C and 80
to 25 C, at a temperature ramp of 0.1 C min1. (B) van't Hoﬀ plot for
the calculation of thermodynamic parameters of the TaLPMO9A
unfolding and refolding. Solid and hollow squares represent the
unfolding and refolding, respectively.
29740 | RSC Adv., 2019, 9, 29734–29742Finally, the refolding kinetics of TaLPMO9A were monitored
by recording the change in ellipticity at 222 nm for 3 h. TaLP-
MO9A was rst subjected to unfolding at 80 C for 10 min then
the refolding kinetics were determined by cooling it down
within 2 min to diﬀerent temperatures (from 60 to 68 C). At
60 C the unfolded TaLPMO9A regained 50% of its folded
conformation within 3 min of incubation (Fig. 7B). Despite the
fast initial rate, it took more than 60 min to reach a 90% folded
state. At higher temperatures, such as 68 and 66 C, it does not
return to its fully folded state aer 3 h of incubation. This shows
that the refolding process of TaLPMO9A is much slower at
temperatures close to Tm. In case of lower temperatures such as
60, 62 and 64 C, the refolding process tends to be faster. The
rate of TaLPMO9A refolding (kf) was calculated from single
exponential t (Fig. S7C†) of data shown in Fig. 6B. The acti-
vation energy of refolding (Efa) was derived from the slope of the
Arrhenius plot for the rate of refolding (Fig. S7D†) and was
estimated to be 181 kJ mol1.Conclusions
An extensive study of the thermal unfolding and refolding of
a fully copper loaded TaLPMO9A was conducted using CD
spectroscopy. Our resuslts reveal high structural stability at
elevated temperatures and reversible thermal unfolding.
TaLPMO9A retains more than 80% of its activity aer 30 min of
incubation at 100 C. The onset of unfolding and refolding is
strongly dependent on the heating rate. The catalytic activity of
TaLPMO9A, measured by Amplex® Red and PASC oxidation
assays, was fully restored aer an unfolding/refolding cycle.
Finally, the Tm of the deglycosylated as well as the apo-
TaLPMO9A are lower than for the native, copper loaded,
TaLPMO9A, yet both also fully refold upon cooling. The higher
thermostability of native TaLPMO9A may be ascribed to its
glycosylation. Additionally, experiments with b-ME show that
disulphide bonds are retained during thermal unfolding andThis journal is © The Royal Society of Chemistry 2019
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View Article Onlineare essential for the refolding of TaLPMO9A. CD provides
structural information on average for all the states in solution
while allowing us to understand the functional stability and
thermodynamic parameters of this unique protein during an
unfolding/refolding cycle. The knowledge of unfolding/
refolding kinetic (Tm, rates) and thermodynamic parameters
(DH, DS) will be especially valuable when using TaLPMO9A
independently or as part of the enzyme cocktail in enzymatic
biomass conversion. This work contributes to the fast-growing
eld of enzyme deconstruction of lignocellulose and, in
particular, to the industrial application of LPMOs below their
melting temperatures.Conﬂicts of interest
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